07/09/2025
4:16 PM | Jahr Robert Charles (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2025
4:17 PM | Jahr Robert Charles (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
3:31 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
4:24 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
| Form SCHEDULE 13D/A | |
05/28/2025
4:20 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:36 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 424B5 | |
04/10/2025
4:28 PM | Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SCHEDULE 13G/A | |
03/30/2025
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form EFFECT | |
03/28/2025
3:44 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 424B3 | |
03/12/2025
8:11 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for OTLK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oncobiologics and its competitors with MarketBeat's FREE daily newsletter. |
03/12/2025
7:56 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4/A | |
03/09/2025
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form EFFECT | |
02/28/2025
3:37 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/28/2025
7:17 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
3:38 PM | Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:14 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
3:16 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form DEF 14A | |
02/10/2025
3:19 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form ARS | |
02/06/2025
3:40 PM | Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:46 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form PRE 14A | |
01/31/2025
3:39 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
4:04 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/23/2025
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 10-K/A | |
01/22/2025
3:17 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025
4:16 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
3:30 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/27/2024
7:14 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:27 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
11:26 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:55 PM | GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
| Form SC 13G/A | |
10/03/2024
8:22 PM | Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
THURMAN RANDY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:53 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
08/14/2024
6:48 AM | Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
